Cardinal Health Inc.
Cardinal Health Inc. (CAH): 6 pipeline candidates · 1 upcoming catalyst · ~27 mo cash runway · 1 clinical trial. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
27.4 months
N/A
Lead: Approved
6 candidates
1 upcoming, next in ~957d
0 buys · 4 sells (180d)
A transparent, data-derived signal for Cardinal Health Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$53.0B
Cash
$2.8B
Quarterly Burn
$1.5B
Runway
27.4 mo
Revenue
$65.6B
Cash Runway vs Catalysts
A catalyst falls after projected cash runway — potential financing / dilution risk before it hits.
Pipeline (6 candidates)
| Drug | Phase |
|---|---|
| ammonia n 13 | Approved |
| ammonia n 13 | Approved |
| fludeoxyglucose f18 | Approved |
| lymphoseek kit | Approved |
| sodium fluoride f-18 | Approved |
| technetium tc 99m sestamibi | Approved |
Upcoming Catalysts (1)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
1,422
Total value held
$43.46B
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 30,577,418 | $6.46B |
| blackrock, inc. | 28,494,855 | $6.02B |
| vanguard portfolio management llc | 13,732,309 | $2.90B |
| state street corp | 12,074,518 | $2.55B |
| geode capital management, llc | 6,580,532 | $1.39B |
| morgan stanley | 4,954,328 | $1.05B |
| wellington management group llp | 4,276,152 | $903.6M |
| fmr llc | 4,243,240 | $896.6M |
| wcm investment management, llc | 4,006,636 | $826.6M |
| bank of america corp /de/ | 2,881,765 | $608.9M |
Showing top 10 of 1,422 institutional holders of Cardinal Health Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Cardinal Health Inc.'s pipeline?
Cardinal Health Inc. (CAH) has 6 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Cardinal Health Inc.'s lead drug candidate?
Cardinal Health Inc.'s most advanced tracked candidate is ammonia n 13 (Approved).
What is Cardinal Health Inc.'s next catalyst?
Cardinal Health Inc.'s next tracked catalyst is a Patent_Expiry event — "Patent/Exclusivity Expiry: LYMPHOSEEK KIT" — expected January 30, 2029.
What is Cardinal Health Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Cardinal Health Inc. has approximately 27.4 months of cash runway.
What is Cardinal Health Inc.'s market capitalization?
Cardinal Health Inc.'s market capitalization is approximately $53.0B.
Get the full picture on Cardinal Health Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.